The ﬁrst “Progress in Vaccination against Cancer” took place in Cambridge, UK, in 2001, at a time when many investigators were highly sceptical as to whether any progress could ever be achieved in this endeavour. However, much has changed in the intervening two decades, during which the small intimate PIVAC conferences have been held annually, missing only one year because of the COVID-19 pandemic lockdown. Hence, PIVAC #23 will be taking place in 2024, September 26–28 in Prague, Czech Republic.
It is our pleasure to invite you to present your latest data at this meeting,
and to discuss progress in vaccination against cancer in the historic environs
of Charles University, one Europe´s oldest.
We are looking forward to another excellent PIVAC meeting in the wonderful city of Prague next September, and sincerely we hope that you will be able to join us for this event.
Info about past event see https://www.imrpress.com/…629069971458
The Organizing Committee of PIVAC 2024
Jirina Bartunkova, Institute of Immunology, 2nd Faculty of Medicine,
Charles University, Prague, Czech Republic and Sotio, a.s., Prague,
vice-president of Czech Society for Allergy and Clinical Immunology
Daniel Smrz, Institute of Immunology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic
Jitka Palich-Fucikova, Sotio a.s., Prague and Institute of Immunology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic
Luca Vannucci, The Laboratory of Immunotherapy, Institute of Microbiology, Academy of Science, Prague, Czech Republic, President of Czech Society for Immunology
Steering Committee of PIVAC 2024
Graham Pawelec, University of Tuebingen, Germany
Costas Baxevanis, St.Savvas Cancer Hospital, Athens, Greece